The epidemiology of prostate cancer

CH Pernar, EM Ebot, KM Wilson… - Cold Spring …, 2018‏ - perspectivesinmedicine.cshlp.org
Prostate cancer is a major cause of disease and mortality among men, and each year 1.6
million men are diagnosed with and 366,000 men die of prostate cancer. In this review, we …

Metastasis: from dissemination to organ-specific colonization

DX Nguyen, PD Bos, J Massagué - Nature Reviews Cancer, 2009‏ - nature.com
Metastasis to distant organs is an ominous feature of most malignant tumours but the natural
history of this process varies in different cancers. The cellular origin, intrinsic properties of …

Prostate-specific antigen screening and 15-year prostate cancer mortality: a secondary analysis of the CAP randomized clinical trial

RM Martin, EL Turner, GJ Young, C Metcalfe, EI Walsh… - JAMA, 2024‏ - jamanetwork.com
Importance The Cluster Randomized Trial of PSA Testing for Prostate Cancer (CAP)
reported no effect of prostate-specific antigen (PSA) screening on prostate cancer mortality …

Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1-13C]Pyruvate

SJ Nelson, J Kurhanewicz, DB Vigneron… - Science translational …, 2013‏ - science.org
This first-in-man imaging study evaluated the safety and feasibility of hyperpolarized [1-13C]
pyruvate as an agent for noninvasively characterizing alterations in tumor metabolism for …

Prostate-cancer mortality at 11 years of follow-up

FH Schröder, J Hugosson, MJ Roobol… - … England Journal of …, 2012‏ - Mass Medical Soc
Background Several trials evaluating the effect of prostate-specific antigen (PSA) testing on
prostate-cancer mortality have shown conflicting results. We updated prostate-cancer …

Predicting 15-year prostate cancer specific mortality after radical prostatectomy

SE Eggener, PT Scardino, PC Walsh, M Han… - The Journal of …, 2011‏ - auajournals.org
Purpose: Long-term prostate cancer specific mortality after radical prostatectomy is poorly
defined in the era of widespread screening. An understanding of the treated natural history …

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

L Klotz, L Zhang, A Lam, R Nam, A Mamedov… - Journal of Clinical …, 2010‏ - ascopubs.org
Purpose We assessed the outcome of a watchful-waiting protocol with selective delayed
intervention by using clinical prostate-specific antigen (PSA), or histologic progression as …

Guideline for the management of clinically localized prostate cancer: 2007 update

I Thompson, JB Thrasher, G Aus, AL Burnett… - The Journal of …, 2007‏ - auajournals.org
In December 1995, the AUA published the Report on the Management of Clinically
Localized Prostate Cancer. 1 The document was the culmination of six years of work by 17 …

20-year outcomes following conservative management of clinically localized prostate cancer

PC Albertsen, JA Hanley, J Fine - Jama, 2005‏ - jamanetwork.com
ContextThe appropriate therapy for men with clinically localized prostate cancer is uncertain.
A recent study suggested an increasing prostate cancer mortality rate for men who are alive …

SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression

Z Ding, CJ Wu, GC Chu, Y **ao, D Ho, J Zhang… - Nature, 2011‏ - nature.com
Effective clinical management of prostate cancer (PCA) has been challenged by significant
intratumoural heterogeneity on the genomic and pathological levels and limited …